DRUG ENFORCEMENT ADMINISTRATION ISSUES NOTICE: ADJUSTMENT TO THE AGGREGATE PRODUCTION QUOTA FOR LISDEXAMFETAMINE AND D-AMPHETAMINE (FOR CONVERSION) FOR 2025 PURSUANT TO 21 U.S.C. 826(H)

WASHINGTON, Sept. 19 -- Drug Enforcement Administration has issued a notice called: Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2025 Pursuant to 21 U.S.C. 826(h).

The notice was published in the Federal Register on Sept. 19 by Heather Achbach, Federal Register Liaison Officer, Drug Enforcement Administration.

Summary: The Drug Enforcement Administration (DEA) is adjusting the 2025 aggregate production quota for the schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion). In making this determination, DEA has considered the factors set forth in 21 CFR 1303.13(b) in accordance with 21 U.S.C. 826(a) and is expediting publication of this determination t...